CXCL13/CXCR5 signaling axis in cancer

相关推荐

• Cell|剪接体靶向疗法能在三阴性乳腺癌中触发抗病毒免疫反应

  许多致癌性损伤解除了RNA剪接的调控,常常导致肿瘤对剪接体靶向治疗(STTs)的超敏反应.然而,stt选择性杀死癌症的机制仍不清楚. 在此,我们发现错误剪接的RNA本身是通过病毒模拟杀死肿瘤的分子触发 ...

• Cancer Immu Res:如何降低癌细胞的恶化速率

  Richmond说,对肿瘤中免疫细胞和趋化因子的深入分析显示出令人惊讶.除了减少肿瘤中的MDSC外,研究人员还发现杀死肿瘤细胞的B细胞(B1b型)和CD8 + T细胞的数量增加,同时趋化因子CXCL1 ...

• 看完这篇文章，你还会觉得SCI难吗

  废话不多说,我们直接上文章:Identification of Key Genes in Thyroid Cancer Microenvironment 文章摘要: Background: Tumor ...

• CXCL13/CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3K/AKT/mTOR Pathway in

  The chemokine ligands and their receptors play critical roles in cancer progression and patients out ...

• Identification of CXCL13/CXCR5 axis's crucial and complex effect in human lung adenocarcinoma.

  Immune escape and low response to immunotherapy are crucial challenges in present lung cancer treatm ...

• Signaling via the CXCR5/ERK pathway is mediated by CXCL13 in mice withbreast cancer

  Breast cancer is the most common cause of cancer‑associated mortality andthe most frequently diagnos ...

• CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond

  It is well-established that the chemokine C-X-C motif ligand 13 (CXCL13) and its receptor, the G-pro ...

• The Role of CXCL13 and CXCL9 in Early Breast Cancer

  Background Chemokines, cytokines in the immune microenvironment of tumors, may be associated with pa ...

• Cancer Res：表达MDA-7/IL-24的T细胞可广泛地识别和杀死癌症

  在之前的研究中,科学家们已发现一种称为IL-24的蛋白以多种不同的方式攻击各种癌症.在一项新的研究中,通过T细胞工程,来自美国弗吉尼亚联邦大学的研究人员发现利用T细胞将编码IL-24的基因(称为MDA ...

• CXCL13

  CXCL13, an inflammatory factor in the microenvironment, plays a vital role in the progression of inf ...

• CXCL13 inhibition induce the apoptosis of MDA

  OBJECTIVE Treatment of the high-risk triple negative breast cancer (TNBC) is a critical clinical cha ...

• 使用cBio Cancer Genomics Portal综合分析癌症基因和临床资料 | 科研动力

  cBio Cancer Genomics Portal提供了研究分析癌症基因数据的可视化工具,cBioPortal可以帮助癌症组织和细胞学研究得到的分子学数据认识和理解遗传.表观遗传.基因表达和蛋白质 ...